Preferred Dental Technologies Inc. (CSE: PDTI, US OTC: PDTTF), continues to accomplish development of its digital dental technologies. The primary digital design features 3D printing solutions as well as accommodating current digital milling technologies. The 3D design also retains all the standard features of the EAS Series of dental abutment components’ unique features. This patented design is the only one of its kind and represents PDTI’s answer to the future of dental procedures as it provides the dental implant industry with a single system which bridges traditional and digital manufacturing techniques using the same base platform.
Throughout the design process, we have also recognized the need for necessary tracking requirements to ensure quality control and traceability for regulatory purposes. Having identified a gap in tracking processes which are currently available, the challenge was to find a solution that could provide tracking from our factory to end user. This tracking would need to provide data for warranty, recall and identifying counterfeiting of the PDTI patented EAS suite of digital products.
The only technology which provides a scalable solution exists in the adoption of a blockchain based platform. We have been in contact with strategic partners who are developing compatible technologies which we anticipate will allow us to successfully fill this reporting gap. We expect to enter into a letter of intent within the next few days with one such strategic partner to utilize their blockchain based system.
About PDTI Preferred Dental Technologies Inc. (PDTI) has been established to advance development and commercialization of various evolutionary and disruptive technologies in the dental implant industry.
MISSION – INNOVATIVE & PRACTICAL SOLUTIONS FOR THE DENTAL INDUSTRY
On behalf of Preferred Dental Technologies Inc. Erik Siegmund Chief Executive Officer Email: firstname.lastname@example.org Tel: 204.691.3722 www.prefdent.com
This news release may contain forward-looking information which is not comprised of historical facts. Forwardlooking information involves risks, uncertainties and other factors that could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forwardlooking information. Forward-looking information in this news release may include, but is not limited to, the Company's objectives, goals or future plans. Factors that could cause actual results to differ materially from such forward-looking information include, but are not limited to, those risks set out in the Company's public documents filed on SEDAR. Although the Company believes that the assumptions and factors used in preparing the forwardlooking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. The Company disclaims any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither The Canadian Securities Exchange nor its Regulations Services Provider (as that term is defined in the policies of The Canadian Securities Exchange accepts any responsibility for the adequacy or accuracy of this release.
#DentalImplants #DentalAbutments #DetnalTechnology #HealthandWellness #InvestinginHealth #CBD #Cannabis #InvestinginCannabis #CannabisStocks #SmallCapStocks #BlockChainSolutions #TechStocks #FrontierMCG